Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, announced today that its board of directors has authorized the repurchase of up to $750 million of shares of the company’s common stock.
This program is in addition to the $500 million repurchase program announced in January 2025, which is anticipated to be fully executed by the end of the first quarter of 2026.
The company had approximately 118.6 million shares outstanding as of September 8, 2025. This new authorization represents approximately 9.0 percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market or through negotiated transactions.
“Henry Schein’s decision to repurchase shares reflects the confidence we have in our 2025–2027 BOLD+1 strategic plan and its potential to deliver sustainable growth and value,” said Ronald N. South, senior vice president and chief financial officer. “With the support of a strong balance sheet, we are well positioned to serve our markets and further expand the depth and reach of our health care solutions.”
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.
Our business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A Fortune 500 company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The company’s sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Source: www.henryschein.com
News 16 April 2026
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...
Products 08 April 2026
Henry Schein Expands Maxima Family With the Maxima Advanced Ultrasonic Cleaner MA100
The newest addition to Henry Schein’s Maxima family of performance handpieces, the MA100 was built on the same technology that is used in the Maxima Advanced Ultrasonic Cleaner MA210—the 2-gallon...
A total digital sensor solution, the Carina Digital Intraoral Sensor from Henry Schein offers simplicity and versatility with 2 sizes for patient comfort.
Henry Schein Orthodontics has introduced Aria Expressions Champagne Gold brackets, now available in a refined new shade designed to help orthodontic practices stand out.
News 16 March 2026
Henry Schein Dental confirms its presence at the British Dental Industry Association’s (BDIA) Dental Showcase, that will take place in London from 13 to 14 March 2026. Henry Schein’s stand number...
The Sonicare brand’s first electric toothbrush powered by on-device AI and real-time spatially aware guidance helps patients brush with greater coverage and confidence for ultimate
News 15 July 2026
Young Innovations, a leading global manufacturer and distributor of dental supplies and equipment, announced the appointment of Rebecca Whitney as Chief Executive Officer, effectiv
For the second year in a row, the American Association of Orthodontists will celebrate Smiles at 7 Day on July 7.
Achievement and service take center stage as the University of Colorado Anschutz School of Dental Medicine honors the Doctor of Dental Surgery (DDS) Class of 2026.
Oral pathology 15 July 2026
This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...